Evaluation of Filler Injection for Chin Profile Enhancement
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age22-55
SponsorUniversity of Pennsylvania
About this trial
The goal of this prospective study is to analyze volumetric changes in the lower face after hyaluronic acid filler injections over 90 days.
The primary aim of the study is to quantify volume change of the lower face rea over time after injection of filler. The secondary aim is to collect patient related outcomes (PROs) via FACE-Q.
Participants will receive hyaluronic acid filler injections (Restylane Lyft(for contouring of the chin. Each patient will receive FDA approved dosages of filler to the lower face region to treat chin regression or chin contouring, as per FDA approved indications.
Prior to injections patients will be imaged with 3-dimensional photogrammetry. Subjects will return post-injection in 2 weeks, 1 month, and 3 moths for re-imaging.
Eligibility criteria
Qualifiers
Age 22-55
Patients interested in chin profile enhancement.
Participants must sign the informed consent form.
Disqualifiers
Prior filler for facial contouring
Filler injection within the past 12 months or during duration of study
Prior facial cosmetic surgery (i.e.. facelift)
Prior facial trauma (i.e.. orbital fracture)
Trial design
Treatments tested in this trial
- HA Filler
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov